文献速递中毒与环境急症心脑血管急症

血清S100蛋白可预测草甘膦或草铵膦中毒患者的意识改变

Serum S100 protein could predict altered consciousness in glyphosate or glufosinate poisoning patients.
PubMed 文献 · Clin Toxicol (Phila) · 2017-03-16
一句话结论草甘膦或草铵膦中毒患者入院时血清S100B≥0.0965 μg/L预测神经学表现的敏感度92%、特异度82%,尚需大型前瞻队列证实。

该试点研究纳入40例草甘膦或草铵膦中毒患者(草甘膦23例、草铵膦17例),住院期间观察意识改变和癫痫发作,入院时用E170系统电化学发光免疫法测血清S100B。40例中12例出现神经学表现,中位出现时间21.5小时(IQR 8.25–24.75)。有神经学表现组入院S100B为0.148 μg/L(IQR 0.128–0.248),无神经学表现组为0.072 μg/L(IQR 0.047–0.084),p<.001。ROC曲线下面积0.894(95%CI 0.791–0.998);S100B取0.0965时预测神经学表现的敏感度92%、特异度82%。作者认为S100B是草甘膦和草铵膦中毒神经学并发症的显著预测因子,但需大型前瞻队列证实。

要点

  • 草甘膦或草铵膦中毒患者入院S100B有神经学表现组0.148 μg/L(IQR 0.128–0.248)vs 无神经学表现组0.072 μg/L(IQR 0.047–0.084),p<.001。
  • 40例中12例出现神经学表现,中位出现时间21.5小时(IQR 8.25–24.75),提示住院期间需持续观察意识与癫痫。
  • S100B预测神经学表现的ROC曲线下面积0.894(95%CI 0.791–0.998)。
  • S100B取0.0965时预测神经学表现敏感度92%、特异度82%。
  • 作者认为S100B是草甘膦和草铵膦中毒神经学并发症的显著预测因子,但需大型前瞻队列证实。

适用人群与场景

  • 草甘膦或草铵膦中毒患者共40例,其中草甘膦中毒23例、草铵膦中毒17例。

诊断标准与关键阈值

  • S100B取0.0965时预测草甘膦和草铵膦中毒神经学表现的敏感度92%、特异度82%。

红旗征与不能漏的情况

  • 意识改变和癫痫发作是草铵膦中毒的重要中枢神经系统并发症,也可能发生于重度草甘膦中毒。

研究设计与关键结果

  • 试点研究纳入40例患者(草甘膦中毒23例、草铵膦中毒17例),住院期间观察意识改变和癫痫发作。
  • 40例中12例出现神经学表现,中位出现时间21.5小时(IQR 8.25–24.75)。
  • 入院S100B有神经学表现组0.148 μg/L(IQR 0.128–0.248)vs 无神经学表现组0.072 μg/L(IQR 0.047–0.084),p<.001。
  • ROC曲线分析显示S100B是草甘膦和草铵膦中毒神经学表现的显著预测因子,曲线下面积0.894(95%CI 0.791–0.998)。
  • S100B取0.0965时预测神经学表现的敏感度92%、特异度82%。

证据类型、等级与局限

  • 证据类型:试点研究。
  • 局限:作者指出需大型前瞻队列证实该发现。

对床旁实践的改变

  • 作者认为S100B是草甘膦和草铵膦中毒患者神经学并发症的显著预测因子,但需大型前瞻队列证实。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Central nervous system (CNS) complications such as seizures and reduced consciousness are important in glufosinate and may occur in severe glyphosate poisoning. The aim of this study was to assess the possible role of serum S100B protein as a biochemical marker of CNS complications associated with glyphosate or glufosinate poisoning.

METHODS: The study enrolled 40 patients (23 glyphosate poisoning and 17 glufosinate poisoning). Altered consciousness and seizure were observed during hospitalization. S100B level was measured with fully automated modular analytic E170 system using electrochemoluminometric immunoassay.

RESULTS: Among 40 patients, neurologic features were observed in 12 patients with a median time to onset of 21.5 (IQR 8.25-24.75) h. Serum S100B concentrations measured on admission were higher in the group with neurologic features than in the group without neurologic features [0.148 μg/L (IQR 0.128-0.248) vs. 0.072 μg/L (IQR 0.047-0.084), p < .001]. Univariate analysis of measured patient raw parameters using a ROC curve showed that S100B was a significant predictor of neurologic features in glyphosate and glufosinate poisoning. The area under the ROC curve was 0.894 (95% confidential interval 0.791-0.998). When S100B was set at 0.0965, its sensitivity and specificity for predicting neurologic features in glyphosate and glufosinate poisoning were 92% and 82%, respectively.

CONCLUSIONS: In our pilot study, S100B was a significant predictor of neurologic complications in patients with glyphosate and glufosinate poisoning. Large prospective cohorts are needed to confirm this finding.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Lee JW, Choi YJ, Park S, et al. Serum S100 protein could predict altered consciousness in glyphosate or glufosinate poisoning patients. Clin Toxicol (Phila). 2017. PMID: 28301275. doi:10.1080/15563650.2017.1286013

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。